Fundraising Fox

MOMA Therapeutics

3 known investors

momatx.com ↗

Moma Therapeutics is a biotechnology company developing precision medicines by targeting molecular machines that drive human disease. It focuses on drug discovery in the biopharmaceutical space.

Biotech

Investors · 3

Nextech InvestZurich · $648K – $3.2M
Third Rock VenturesBoston · $100K – $5M
Goldman SachsreportedNew York

Founder mafia

2 people who came through MOMA Therapeutics went on to found or lead other companies.

Reid HuberDirectorFounded Rapport Therapeutics +1Christoph LengauerCSO & co-founderFounded Celsius Therapeutics +1

In the news

BioCentury - May 10 Quick Takes: ‘molecular machines’ company MOMA lands $150M series Bbiocentury.com · May 2022MOMA Therapeutics rakes in $150m Series Bventurecapitaljournal.com · May 2022MOMA Therapeutics Announces $150 Million Series B Financing - MOMA Therapeuticsmomatx.com · May 2022MOMA Therapeutics Raises $150 Million to Advance Precision Oncology Programs - Global Genesglobalgenes.org · May 2022Moma Therapeutics aims at molecular machines with $86M raise - MOMA Therapeuticsmomatx.com · Apr 2020

Frequently asked questions

What does MOMA Therapeutics do?
Moma Therapeutics is a biotechnology company developing precision medicines by targeting molecular machines that drive human disease. It focuses on drug discovery in the biopharmaceutical space.
Who are MOMA Therapeutics's investors?
MOMA Therapeutics's investors include Nextech Invest, Third Rock Ventures, Goldman Sachs.